Systematic Review

Published on 11 Jul 2024

Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis

in Inflammation Pharmacology

Ziwei Jiang
Yue Zou
Guangyao Li
Sixuan Zhao
Wei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376262

1,062 views

Review

Published on 11 Jul 2024

Critical signaling molecules in the temporomandibular joint osteoarthritis under different magnitudes of mechanical stimulation

in Inflammation Pharmacology

Yuqi Liu
Fangwen Jia
Kangya Li
Chao Liang
Xiao Lin
Wei Geng
Yanxi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419494

1,169 views

Correction

Published on 10 Jul 2024

Corrigendum: Xenon attenuated neonatal lipopolysaccharide exposure induced neuronal necroptosis and subsequently improved cognition in juvenile rats

in Inflammation Pharmacology

Zhimin Liao
Xiaofeng Ou
Cheng Zhou
Daqing Ma
Hailin Zhao
Han Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438335

389 views

Original Research

Published on 08 Jul 2024

Knockout of C1q/tumor necrosis factor-related protein-9 aggravates cardiac fibrosis in diabetic mice by regulating YAP-mediated autophagy

in Inflammation Pharmacology

Shiyan Ruan
Jun Li
Shengyun Lei
Shaomeng Zhang
Dan Xu
Anju Zuo
Linxi Li
Yuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407883

1,205 views

Review

Published on 08 Jul 2024

A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets

in Inflammation Pharmacology

Priyanka Soni
Navneet Ammal Kaidery
Sudarshana M. Sharma
Irina Gazaryan
Sergey V. Nikulin
Dmitry M. Hushpulian
Bobby Thomas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390798

2,410 views

Systematic Review

Published on 08 Jul 2024

What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022

in Inflammation Pharmacology

Yun Li
Cheng Xie
Xiaoliang Ding
Ziyang Wu
Jingjing Zhang
Jianguo Zhu
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376708

862 views

Original Research

Published on 03 Jul 2024

Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells

in Inflammation Pharmacology

Vivien R. Sutton
Sally V. Watt
Hedieh Akhlaghi
David C. Cipolla
Kuan-Ju Chen
Daniel LaSala
Patrick P. McDonald
Paul A. Beavis
Isabelle Munoz
Adrian W. Hodel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396710

1,636 views

Original Research

Published on 01 Jul 2024

A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank

in Inflammation Pharmacology

Peng-Cheng Ma
Qi-Mei Li
Rui-Ning Li
Chang Hong
Hao Cui
Zi-Yong Zhang
Yan Li
Lu-Shan Xiao
Hong Zhu
Lin Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1281095

1,570 views
1 citation

Original Research

Published on 28 Jun 2024

Adenosine A2A receptor as a potential regulator of Mycobacterium leprae survival mechanisms: new insights into leprosy neural damage

in Inflammation Pharmacology

Plinio Marcos Freire dos Santos
Chyntia Carolina Díaz Acosta
Thabatta Leal Silveira Andrezo Rosa
Michelle Harumi Ishiba
André Alves Dias
Antonio Marcos Rodrigues Pereira
Luísa Domingos Gutierres
Melissa Pontes Pereira
Matheus da Silva Rocha
Patrícia Sammarco Rosa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399363

2,177 views

Review

Published on 21 Jun 2024

Gut-directed therapy in Parkinson’s disease

in Inflammation Pharmacology

Laura Benvenuti
Clelia Di Salvo
Gabriele Bellini
Luisa Seguella
Francesco Rettura
Giuseppe Esposito
Luca Antonioli
Roberto Ceravolo
Nunzia Bernardini
Carolina Pellegrini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407925

1,785 views
1 citation

Editorial

Published on 20 Jun 2024

Editorial: Recent advances in immunometabolism

in Inflammation Pharmacology

Ishtiaq Jeelani
Allah Nawaz
Hafiz Muhammad Asif
Ishtiaq Ahmad
Arijeet K. Gattu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422816

798 views

Correction

Published on 18 Jun 2024

Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect

in Inflammation Pharmacology

Stefania Petrosino
Marika Cordaro
Roberta Verde
Aniello Schiano Moriello
Gabriele Marcolongo
Carlo Schievano
Rosalba Siracusa
Fabiana Piscitelli
Alessio F. Peritore
Rosalia Crupi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441203

519 views
1 citation

Review

Published on 12 Jun 2024

The role of autophagy in Parkinson’s disease: a gender difference overview

in Inflammation Pharmacology

Laura Cucinotta
Deborah Mannino
Alessia Filippone
Adele Romano
Emanuela Esposito
Irene Paterniti

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408152

859 views

Original Research

Published on 12 Jun 2024

Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit

in Inflammation Pharmacology

Anne Barbot
Michele Lheritier-Barrand
Margarita Murrieta-Aguttes
Maud Leonetti
Jimmy Vernaz
Song Huang
Samuel Constant
Bernadett Boda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393702

1,155 views

Review

Published on 04 Jun 2024

Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?

in Inflammation Pharmacology

Marzia Friuli
Christian Sepe
Elisabetta Panza
Cristina Travelli
Irene Paterniti
Adele Romano

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407336

1,397 views

Original Research

Published on 30 May 2024

Melatonin modulates neuroinflammatory response and microglial activation in mice exposed to dim blue light at night

in Inflammation Pharmacology

Chao Song
Zhaotaize Suo
Zixu Wang
Jing Cao
Yulan Dong
Yaoxing Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1416350

1,573 views

Navigation group

Articles

Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis

Critical signaling molecules in the temporomandibular joint osteoarthritis under different magnitudes of mechanical stimulation

Corrigendum: Xenon attenuated neonatal lipopolysaccharide exposure induced neuronal necroptosis and subsequently improved cognition in juvenile rats

Knockout of C1q/tumor necrosis factor-related protein-9 aggravates cardiac fibrosis in diabetic mice by regulating YAP-mediated autophagy

A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets

What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022

Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells

A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank

Adenosine A2A receptor as a potential regulator of Mycobacterium leprae survival mechanisms: new insights into leprosy neural damage

Gut-directed therapy in Parkinson’s disease

Editorial: Recent advances in immunometabolism

Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect

The role of autophagy in Parkinson’s disease: a gender difference overview

Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit

Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?

Melatonin modulates neuroinflammatory response and microglial activation in mice exposed to dim blue light at night